DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DBAN - DE000A1TNUT7 - Common Stock
24.7 EUR
-0.9 (-3.52%)
We assign a fundamental rating of 3 out of 10 to DBAN. DBAN was compared to 121 industry peers in the Capital Markets industry. DBAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. DBAN has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- DBAN had positive earnings in the past year.
- DBAN had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: DBAN reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: DBAN reported negative operating cash flow in multiple years.
1.2 Ratios
- DBAN has a Return On Assets of 3.38%. This is in the better half of the industry: DBAN outperforms 66.14% of its industry peers.
- DBAN has a Return On Equity (4.81%) which is comparable to the rest of the industry.
- DBAN has a Return On Invested Capital (2.53%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.38% | ||
| ROE | 4.81% | ||
| ROIC | 2.53% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 31.10%, DBAN is doing good in the industry, outperforming 78.74% of the companies in the same industry.
- In the last couple of years the Profit Margin of DBAN has declined.
- The Operating Margin of DBAN (32.22%) is better than 71.65% of its industry peers.
- In the last couple of years the Operating Margin of DBAN has declined.
- Looking at the Gross Margin, with a value of 89.98%, DBAN belongs to the top of the industry, outperforming 90.55% of the companies in the same industry.
- DBAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.22% | ||
| PM (TTM) | 31.1% | ||
| GM | 89.98% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
- The number of shares outstanding for DBAN has been reduced compared to 1 year ago.
- The number of shares outstanding for DBAN has been increased compared to 5 years ago.
- The debt/assets ratio for DBAN is higher compared to a year ago.
2.2 Solvency
- DBAN has an Altman-Z score of 1.77. This is a bad value and indicates that DBAN is not financially healthy and even has some risk of bankruptcy.
- DBAN has a Altman-Z score of 1.77. This is in the better half of the industry: DBAN outperforms 69.29% of its industry peers.
- DBAN has a debt to FCF ratio of 93.97. This is a negative value and a sign of low solvency as DBAN would need 93.97 years to pay back of all of its debts.
- DBAN has a Debt to FCF ratio (93.97) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.31 indicates that DBAN is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.31, DBAN is in the better half of the industry, outperforming 69.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 93.97 | ||
| Altman-Z | 1.77 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.84 indicates that DBAN may have some problems paying its short term obligations.
- DBAN's Current ratio of 0.84 is in line compared to the rest of the industry. DBAN outperforms 52.76% of its industry peers.
- DBAN has a Quick Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
- DBAN has a Quick ratio (0.84) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
- DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.70%.
- The Earnings Per Share has been decreasing by -3.13% on average over the past years.
- The Revenue for DBAN has decreased by -10.87% in the past year. This is quite bad
- Measured over the past years, DBAN shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
3.2 Future
- Based on estimates for the next years, DBAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.27% on average per year.
- Based on estimates for the next years, DBAN will show a decrease in Revenue. The Revenue will decrease by -7.69% on average per year.
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5YN/A
Revenue Next Year-22.08%
Revenue Next 2Y-6.46%
Revenue Next 3Y-7.69%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.92, which indicates a correct valuation of DBAN.
- Based on the Price/Earnings ratio, DBAN is valued a bit cheaper than the industry average as 69.29% of the companies are valued more expensively.
- DBAN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.38.
- A Price/Forward Earnings ratio of 12.27 indicates a correct valuation of DBAN.
- 84.25% of the companies in the same industry are more expensive than DBAN, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. DBAN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.92 | ||
| Fwd PE | 12.27 |
4.2 Price Multiples
- DBAN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 225.86 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- DBAN's earnings are expected to decrease with -15.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.91%, DBAN has a reasonable but not impressive dividend return.
- DBAN's Dividend Yield is a higher than the industry average which is at 3.07.
- DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.91% |
5.2 History
- The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
- 73.85% of the earnings are spent on dividend by DBAN. This is not a sustainable payout ratio.
- DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.85%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
FRA:DBAN (1/16/2026, 7:00:00 PM)
24.7
-0.9 (-3.52%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-10 2026-03-10/amc
Inst Owners11.66%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap464.36M
Revenue(TTM)96.86M
Net Income(TTM)30.13M
Analysts89.23
Price Target37.19 (50.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.91% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP73.85%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.48%
PT rev (3m)-5.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.92 | ||
| Fwd PE | 12.27 | ||
| P/S | 4.79 | ||
| P/FCF | 225.86 | ||
| P/OCF | 175.56 | ||
| P/B | 0.74 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)1.46
EY5.91%
EPS(NY)2.01
Fwd EY8.15%
FCF(TTM)0.11
FCFY0.44%
OCF(TTM)0.14
OCFY0.57%
SpS5.15
BVpS33.3
TBVpS30.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.38% | ||
| ROE | 4.81% | ||
| ROCE | 3.86% | ||
| ROIC | 2.53% | ||
| ROICexc | 2.68% | ||
| ROICexgc | 2.85% | ||
| OM | 32.22% | ||
| PM (TTM) | 31.1% | ||
| GM | 89.98% | ||
| FCFM | 2.12% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-35.11%
ROICexgc growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 93.97 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 6.82% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.77 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
Revenue Next Year-22.08%
Revenue Next 2Y-6.46%
Revenue Next 3Y-7.69%
Revenue Next 5YN/A
EBIT growth 1Y-37.36%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-64.73%
EBIT Next 3Y-7.7%
EBIT Next 5YN/A
FCF growth 1Y109.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.05%
OCF growth 3YN/A
OCF growth 5YN/A
DEUTSCHE BETEILIGUNGS AG / DBAN.DE FAQ
What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to DBAN.DE.
What is the valuation status of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Fairly Valued.
What is the profitability of DBAN stock?
DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 4 / 10.
What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?
The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.
What is the earnings growth outlook for DEUTSCHE BETEILIGUNGS AG?
The Earnings per Share (EPS) of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is expected to decline by -71.64% in the next year.